Literature DB >> 6837651

Rifampin-induced nephrotic syndrome and acute interstitial nephritis.

J Neugarten, G R Gallo, D S Baldwin.   

Abstract

The occurrence of renal insufficiency associated with heavy glomerular proteinuria during the course of continuous rifampin therapy in a patient with pulmonary tuberculosis is reported. Renal biopsy demonstrated acute interstitial nephritis, normal glomerular histology, effacement of glomerular epithelial cell foot processes, and electron-dense deposits in mesangial matrix and subendothelial and paramesangial sites. Discontinuation of rifampin was followed by improvement in renal function and abatement of proteinuria. We call attention to the broad clinical and morphologic spectrum of nephrotoxicity which may be induced by rifampin and a variety of other drugs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6837651     DOI: 10.1159/000166685

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  9 in total

1.  Acute interstitial nephritis during rifampicin therapy can be a paradoxical response: a case report.

Authors:  Jan van der Meulen; Gijs M T de Jong; Pieter J Westenend
Journal:  Cases J       Date:  2009-04-03

Review 2.  Glomerular, tubular and interstitial nephritis associated with non-steroidal antiinflammatory drugs. Evidence of a common mechanism.

Authors:  U Ravnskov
Journal:  Br J Clin Pharmacol       Date:  1999-02       Impact factor: 4.335

3.  Acute interstitial nephritis predisposed a six-year-old girl to minimal change nephrotic syndrome.

Authors:  Shori Takahashi; Tomomi Kitamura; Hitohiko Murakami; Koji Hashimoto; Michio Nagata; Kensuke Harada
Journal:  Pediatr Nephrol       Date:  2005-06-08       Impact factor: 3.714

Review 4.  Effects of non-narcotic analgesics on the kidney.

Authors:  P Kincaid-Smith
Journal:  Drugs       Date:  1986       Impact factor: 9.546

5.  Rifampicin-induced minimal change disease is improved after cessation of rifampicin without steroid therapy.

Authors:  Dong Hyuk Park; Sul A Lee; Hyeon Joo Jeong; Tae-Hyun Yoo; Shin-Wook Kang; Hyung Jung Oh
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

6.  Minimal change disease related to rifampicin presenting with acute renal failure during treatment for latent tuberculosis infection: A case report.

Authors:  Jee-Seon Kim; Kyong-Ju Kim; Eun-Young Choi
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

7.  Drug-Induced Lupus Secondary to Ethosuximide in Association with Acute Tubulointerstitial Nephritis and Nephrotic Syndrome.

Authors:  Rasha Aly; Xu Zeng; Kiran Upadhyay
Journal:  Pediatr Rep       Date:  2022-04-14

8.  Rifampin-associated tubulointersititial nephritis and Fanconi syndrome presenting as hypokalemic paralysis.

Authors:  Hong Ki Min; Eun Oh Kim; Sang Ju Lee; Yoon Kyung Chang; Kwang Sun Suh; Chul Woo Yang; Suk Young Kim; Hyeon Seok Hwang
Journal:  BMC Nephrol       Date:  2013-01-16       Impact factor: 2.388

9.  Rifampicin-Associated Secondary Minimal Change Disease Presenting with Nephrotic Syndrome in a Pulmonary Tuberculosis Patient.

Authors:  Satyanand Sathi; Anil Kumar Garg; Manoj Kumar Singh; Virendra Singh Saini; Devinder Vohra
Journal:  Case Rep Nephrol       Date:  2021-04-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.